Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kester

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2021
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapyMiranda H Meeuwsen, Anne K Wouters, Lorenz Jahn, et al.
Blood|February 18, 2010
Allo-HLA reactivity of virus-specific memory T cells is commonAvital L Amir, Lloyd J A D'Orsogna, Dave L Roelen, et al.
Bone Marrow Transplantation|June 6, 2017
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myelomaL E Franssen, M W H Roeven, W Hobo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016
Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2Margot J Pont, Dyantha I van der Lee, Edith D van der Meijden, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2003
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaW A Erik Marijt, Mirjam H M Heemskerk, Freke M Kloosterboer, et al.
Journal of Autoimmunity|June 4, 2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimersWendy W Unger, Jurjen Velthuis, Joana R F Abreu, et al.
Cellular and Molecular Life Sciences : CMLS|September 20, 2023
Human CD34<sup>+</sup>-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8<sup>+</sup> T cell and NK cell responses in vitro and in vivoJesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, et al.
Journal for Immunotherapy of Cancer|June 21, 2022
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinomaRosa A van Amerongen, Renate S Hagedoorn, Dennis F G Remst, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2021
Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responsesJesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, et al.
Molecular Therapy Oncolytics|January 2, 2023
A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2021
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapyMiranda H Meeuwsen, Anne K Wouters, Lorenz Jahn, et al.
Blood|February 18, 2010
Allo-HLA reactivity of virus-specific memory T cells is commonAvital L Amir, Lloyd J A D'Orsogna, Dave L Roelen, et al.
Bone Marrow Transplantation|June 6, 2017
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myelomaL E Franssen, M W H Roeven, W Hobo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016
Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2Margot J Pont, Dyantha I van der Lee, Edith D van der Meijden, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2003
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaW A Erik Marijt, Mirjam H M Heemskerk, Freke M Kloosterboer, et al.
Journal of Autoimmunity|June 4, 2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimersWendy W Unger, Jurjen Velthuis, Joana R F Abreu, et al.
Cellular and Molecular Life Sciences : CMLS|September 20, 2023
Human CD34<sup>+</sup>-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8<sup>+</sup> T cell and NK cell responses in vitro and in vivoJesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, et al.
Journal for Immunotherapy of Cancer|June 21, 2022
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinomaRosa A van Amerongen, Renate S Hagedoorn, Dennis F G Remst, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2021
Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responsesJesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, et al.
Molecular Therapy Oncolytics|January 2, 2023
A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.
Pageof 17